[Asia Economy Reporter Park Soyeon] Humasis, a company related to diagnostic kits, is showing strong performance amid the increase in COVID-19 cases and the spread of variant viruses.
As of 2 PM on the 23rd, Humasis is trading at 16,900 KRW on the KOSDAQ market, up 3,900 KRW (30%) from the previous day.
Humasis has a market capitalization of 578.4 billion KRW and ranks 140th on the KOSDAQ. The face value is 100 KRW per share.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
